# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-043161
Filing Date
2021-03-29
Accepted
2021-03-29 16:06:40
Documents
95
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | tm211037-1_10k.htm | 10-K | 1967823
2 | EX-21.1 | tm211037d1_ex21x1.htm | EX-21.1 | 5696
3 | EX-23.1 | tm211037d1_ex23x1.htm | EX-23.1 | 2817
4 | EX-31.1 | tm211037d1_ex31x1.htm | EX-31.1 | 9462
5 | EX-31.2 | tm211037d1_ex31x2.htm | EX-31.2 | 9610
6 | EX-32 | tm211037d1_ex32.htm | EX-32 | 8003
13 | GRAPHIC | tm211037d1-lc_celldexbw.jpg | GRAPHIC | 53229
| Complete submission text file | 0001104659-21-043161.txt |  | 8284947

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE DOCUMENT | cldx-20201231.xml | EX-101.INS | 1785476
8 | XBRL TAXONOMY EXTENSION SCHEMA | cldx-20201231.xsd | EX-101.SCH | 52186
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | cldx-20201231_cal.xml | EX-101.CAL | 63079
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cldx-20201231_def.xml | EX-101.DEF | 229270
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cldx-20201231_lab.xml | EX-101.LAB | 559460
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cldx-20201231_pre.xml | EX-101.PRE | 444976

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 21781764
SIC: 2835 In Vitro & In Vivo Diagnostic Substances